Penn State Health opens new nonalcoholic Fatty Liver Disease Program
Penn State Health opened a new program to diagnose and manage the growing number of patients who have nonalcoholic fatty liver disease. The Penn State Health Fatty Liver Disease Program opened Feb. 10 on limited days each week and will be fully operational on July 1. To refer a patient or schedule an appointment, call 717-531-4950.
Nonalcoholic fatty liver disease is a range of medical conditions caused by a buildup of fat in the liver. The disease often occurs with other conditions like obesity, diabetes, high blood pressure and high cholesterol. Too much fat stored in liver cells causes liver inflammation, which leads to scarring, or cirrhosis. Cirrhosis can lead to loss of liver function, or it can cause primary liver cancer to develop.
Dr. Jonathan Stine leads the Penn State Fatty Liver Disease Program, which will provide comprehensive, multidisciplinary care to adult patients with nonalcoholic fatty liver disease. Services will include hepatology (treatment of liver, gallbladder, bile ducts and pancreas disorders), endocrinology (treatment of hormonal disorders, including diabetes, thyroid problems and high blood pressure), lipid and hypertension control, and exercise and nutrition counseling.
The Fatty Liver Disease Program is located at:
Penn State Health Milton S. Hershey Medical Center
University Physician Center
200 Campus Drive
Entrance 4, Suite 2400
Hershey, PA 17033
If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.